Xofluza
Payments companies reported to CMS as associated with Xofluza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xofluza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xofluza
These are the largest totals companies reported as associated with Xofluza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Frederick Hayden | Charlottesville, VA | Infectious Disease | $15,095.15 |
| Stefan Gravenstein | Norfolk, VA | Geriatric Medicine (Family Medicine) | $11,006.52 |
| Daniel Finn | Bardstown, KY | Pediatrics | $5,640.00 |
| Barry Mclean | Homewood, AL | Internal Medicine | $2,430.00 |
| Arnold Monto | Ann Arbor, MI | $1,450.00 | |
| Adam Lauring | Ann Arbor, MI | Infectious Disease | $1,450.00 |
| Tidence Prince | Maryville, TN | Allergy & Immunology | $120.54 |
| Karen Roden | Knoxville, TN | Nurse Practitioner | $120.54 |
| Michael Caldwell | Poughkeepsie, NY | Internal Medicine | $105.50 |
| Henry Guevara | Austin, TX | Family | $93.62 |
Prescribed Xofluza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.